Evidence map›Paper›PMID 42589354›Full record

ReviewInternational journal of molecular sciences2026

Animal Models of Idiopathic Inflammatory Myopathies: Bridging Mechanistic Insights and Clinical Translation.

Guanyuan Wang, Shaoxin Cui, Lin Yang, Karl J A McCullagh, Cuiqing Ma, Aijing Liu

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Guanyuan WangDepartment of Rheumatology and Immunology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.
Shaoxin CuiDepartment of Rheumatology and Immunology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.
Lin YangDepartment of Rheumatology and Immunology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.
Karl J A McCullaghDiscipline of Physiology, School of Pharmacy & Medical Sciences, Human Biology Building, University of Galway, H91 W5P7 Galway, Ireland.ORCID 0000-0002-0756-2845
Cuiqing MaKey Laboratory of Immune Mechanism and Intervention on Serious Disease in Hebei Province, Department of Immunology, Hebei Medical University, Shijiazhuang 050017, China.ORCID 0000-0001-9021-7040
Aijing LiuDepartment of Rheumatology and Immunology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.ORCID 0000-0002-5762-5592

Funding

Central Government Guides Local Funds for Science and Technology Development 246Z7709GGovernment Foundation of Excellent Clinical Medicine Talent Program of Hebei ZF2025100Medical Science Research Project of Hebei 20250052Medical Science Research Project of Hebei 20250057
6 · The paper itself

Abstract

Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of autoimmune diseases with wide variation in pathogenesis, clinical presentation, and serological profiles, leading to substantial differences in diagnosis, classification, treatment response, and prognosis among patients. Although decades of progress have been made in understanding myositis-specific autoantibodies and molecular pathology, important gaps remain in elucidating disease mechanisms and identifying effective therapeutic targets. Therefore, animal models that recapitulate key characteristics of human IIMs provide an indispensable platform for addressing current limitations in mechanistic research and promoting translational studies. This review comprehensively discusses animal models related to the major clinical-serological subtypes of IIMs, including polymyositis-like T-cell-mediated models, dermatomyositis models, inclusion body myositis models, antisynthetase syndrome models, and immune-mediated necrotizing myopathy models. Particular attention is given to model construction, pathological phenotypes, dominant immune mechanisms, therapeutic applications, and translational limitations. By organizing current models according to subtype-related pathological and immunological features, this narrative review aims to provide a clearer framework for selecting appropriate experimental systems and to facilitate more precise, mechanism-driven myositis research.

Indexed as

Disease Models, AnimalMyositisAnimalsAutoantibodiesHumansTranslational Research, BiomedicalAutoantibodiesanimal modelsidiopathic inflammatory myopathiesimmunopathologypathogenesistranslational medicine

Identifiers

PMID42589354
PMCPMC13467483

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.